|
|
Found results for
patents
1.
|
DEVICE FOR DELIVERY OF SMOKABLE CANNABIS AND MANUFACTURING METHOD FOR SAME
| Application Number |
US2018036553 |
| Publication Number |
2018/227017 |
| Status |
In Force |
| Filing Date |
2018-06-07 |
| Publication Date |
2018-12-13 |
| Owner |
NC3 SYSTEMS (USA)
|
| Inventor |
- Vu, Michael, Viet Thang
- Rothrock, Sarah, Rose
- Bell, Michael, William
- Martinez, Nelson, Miguel Ricardo
- Levy, Aaron
- Stubblefield, Steven
|
Abstract
A delivery device for smokable cannabis and a manufacturing method for same with a defined active cannabis compound. Plant material from a plurality of cannabis plants representing a plurality of cannabis cultivars is harvested based on parent cultivars' active cannabis compound profile. Plant material is shredded to a size range applicable to loading into a smokable device, measured proportions of plant materials are combined to produce a mixed batch -with a projected desirable active cannabis compound profile. Material is then processed, analyzed, loaded into smokable delivery device, labeled and distributed.
IPC Classes ?
- A24B 3/00 - Preparing tobacco in the factory
- A24B 3/08 - Blending tobacco
- A24B 15/00 - Chemical features or treatment of tobaccoTobacco substitutes, e.g. in liquid form
|
2.
|
A SYSTEM AND METHOD ENHANCED CANNABINOID EFFECT DELIVERY
| Application Number |
US2018036359 |
| Publication Number |
2018/226899 |
| Status |
In Force |
| Filing Date |
2018-06-06 |
| Publication Date |
2018-12-13 |
| Owner |
NC3 SYSTEMS (USA)
|
| Inventor |
- Thacker, Larry, Nelson, Jr.
- Vu, Michael, Viet, Thang
- Force, Robert, Daniel
- Thacker, Alexander, Nelson
- Adams, Aaron, Nicholas
|
Abstract
A class of medically-effective formulations comprising cannabinoids, and terpenes, using β-myrcene to improve effectiveness. B-myrcene decreases resistance across the blood-brain barrier for both itself and a plurality of other medically-active compounds such as other terpenes, cannabinoids, and flavonoids. Further, β-myrcene has been determined to raise the saturation level of the cannabinoid receptor CB1 for phytocannabinoids such as delta(9)-tetrahydrocannabinol, and to increase cell membrane permeability for itself as well as cannabinoids, terpenes, flavonoids and other naturally occurring cannabis compounds, thereby improving therapeutic benefits of cannbis formulations.
IPC Classes ?
- A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
- A61K 31/01 - Hydrocarbons
- A61K 31/185 - AcidsAnhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
|
|